| Prev Close | 113.52 |
| Open | 114.35 |
| Day Low/High | 114.02 / 115.20 |
| 52 Wk Low/High | 78.90 / 116.47 |
| Volume | 1.17M |
| Avg Volume | 1.95M |
Zoetis Inc. (ZTS)
114.94
1.40
1.30
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 478.66M |
| Market Cap | 54.32B |
| EPS | 3.00 |
| P/E Ratio | 39.27 |
| Div & Yield | 0.66 (0.51%) |
Latest News
Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?
Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.
Zoetis Is in a Strong Uptrend So Don't Expect Much of a Dip to Buy It
What about the technical story? Let's check out some charts.
3 Pet Product Stocks Ready to Be Unleashed: Dogness, Elanco and Zoetis
Pets can bring significant profits to companies that cater to this niche market.
Institutional Selling, Europe's Economy, Nvidia Earnings Preview: Market Recon
What trader has never both fallen in love with Nvidia, only to eventually feel the scorn of an angry lover's tortured vengeance?
Markets Are Headed For a More Difficult Environment: Market Recon
Santa is on his way... A lot of pressure on the jolly fellow this year.
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer
ZTS discovers, develops, manufactures, and markets veterinary vaccines and medicines.
Zoetis Surges to New Highs: Where to Buy It Now
Let's take the charts and indicators for a walk and see how high they may go in the weeks ahead.
Jim Cramer: 4 Pet-Related Stocks That Are Top Dog
The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.
2 Ways to Play Nvidia Into Earnings: Market Recon
Go long on strong fundamentals, or try this options strategy.
We Are Never Going Back to Easy Markets: Market Recon
Consistency in discipline will make the difference.
Jim Cramer: Follow the Bouncing Equities
Markets start day with a bungee jump.
Maybe This Is Not Really About Inflation -- Market Recon
Overreaction seems to be what markets are good at in this 'golden age of electronic trading.'
How to Play Eight Potential Breakout Stocks
A partial list of names that are showing signs of breaking out Monday.
My Trader Side Prefers Jay Powell; My Economist Side Likes Rules: Market Recon
My economist side would clearly prefer a rules-based approach toward monetary policy.
These Stocks Have Changed Direction
Finding bullish and bearish reversals in the market.
Cramer: As Fed Moves to Tighten, Other Things Come Unraveled
The list begins with oil, but there's a ripple effect.
Animal Health Company Zoetis ZTS Reported Earnings Thursday
The company lowered guidance for FY 2017, which is likely to blame for the company's fall.
Bill Ackman Sells Zoetis, Holds Chipotle
Ackman launched a winning activist campaign at Chipotle last year.
Use Pullback on Zoetis to Do Some Buying
Prices are likely to go higher.
Cramer: Barking Up the Right Tree With Pet Health Stocks
The Mars-VCA deal is yet another sign that pet health is a robust business.
Don't Ignore Agricultural ETFs
One of them made an explosive move earlier this week.
Don't Ignore Agricultural ETFs
One of them made an explosive move earlier this week.
Trending Tickers: ZTS, AGN, WFT, MRO
Zoetis shares were climbing off an earnings beat and raised 2016 guidance.
Jim Cramer: Zoetis Is a Well Run Company
Jim Cramer says Zoetis, an animal health company, is well run.
Cramer: These Themes Stand the Test of Turbulent Times
Teeth, pets, video games, eating at home are evidence of strong theses.
Bullish and Bearish Reversals for the Week
Here's a window into what institutional investors may be doing and how to profit from that.
Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'
It may not be possible for Valeant to wind down its massive debt as quickly as expected, say Deutsche Bank analysts.
